Search research articles
Contact Us
Filters
Showing results (31-40 of 120) with videos related to
Page
of 12
Sort By:
Journal of Clinical Microbiology
|
December 1, 1993
Comparison of three buffers used in the formulation of buffered charcoal yeast extract medium
P H Edelstein, M A Edelstein
Antimicrobial Agents and Chemotherapy
|
September 1, 1980
Susceptibility of Legionella pneumophila to twenty antimicrobial agents
P H Edelstein, R D Meyer
The Journal of Antimicrobial Chemotherapy
|
November 1, 1978
Netilmicin therapy of serious Gram-negative bacillary infections
P H Edelstein, R D Meyer
Diagnostic Microbiology and Infectious Disease
|
April 1, 2000
In vitro activity of quinupristin/dalfopristin (Synercid, RP 59500) against Legionella spp
P H Edelstein, M A Edelstein
Antimicrobial Agents and Chemotherapy
|
April 1, 1993
In vitro activity of RP 74501-RP 74502, a novel streptogramin antimicrobial mixture, against clinical isolates of Legionella species
P H Edelstein, M A Edelstein
Diagnostic Microbiology and Infectious Disease
|
February 17, 1999
In vitro activity of SCH 27899 (Ziracin) against Legionella species
P H Edelstein, M A Edelstein
Journal of Clinical Microbiology
|
April 1, 1985
A new biotype of Legionella dumoffii
P H Edelstein, E P Pryor
Epidemiology and Infection
|
December 1, 1993
Intracellular growth of Legionella pneumophila serogroup 1 monoclonal antibody type 2 positive and negative bacteria
P H Edelstein, M A Edelstein
Journal of Clinical Microbiology
|
November 1, 1983
Oropharyngeal colonization with Legionella pneumophila
J A Bridge, P H Edelstein
Antimicrobial Agents and Chemotherapy
|
January 1, 1991
In vitro activity of azithromycin against clinical isolates of Legionella species
P H Edelstein, M A Edelstein
Page
of 12
Search research articles
Search
Showing results (31-40 of 120) with videos related to
Sort By:
Page
of 12
Journal of Clinical Microbiology
|
December 1, 1993
Comparison of three buffers used in the formulation of buffered charcoal yeast extract medium
P H Edelstein, M A Edelstein
Antimicrobial Agents and Chemotherapy
|
September 1, 1980
Susceptibility of Legionella pneumophila to twenty antimicrobial agents
P H Edelstein, R D Meyer
The Journal of Antimicrobial Chemotherapy
|
November 1, 1978
Netilmicin therapy of serious Gram-negative bacillary infections
P H Edelstein, R D Meyer
Diagnostic Microbiology and Infectious Disease
|
April 1, 2000
In vitro activity of quinupristin/dalfopristin (Synercid, RP 59500) against Legionella spp
P H Edelstein, M A Edelstein
Antimicrobial Agents and Chemotherapy
|
April 1, 1993
In vitro activity of RP 74501-RP 74502, a novel streptogramin antimicrobial mixture, against clinical isolates of Legionella species
P H Edelstein, M A Edelstein
Diagnostic Microbiology and Infectious Disease
|
February 17, 1999
In vitro activity of SCH 27899 (Ziracin) against Legionella species
P H Edelstein, M A Edelstein
Journal of Clinical Microbiology
|
April 1, 1985
A new biotype of Legionella dumoffii
P H Edelstein, E P Pryor
Epidemiology and Infection
|
December 1, 1993
Intracellular growth of Legionella pneumophila serogroup 1 monoclonal antibody type 2 positive and negative bacteria
P H Edelstein, M A Edelstein
Journal of Clinical Microbiology
|
November 1, 1983
Oropharyngeal colonization with Legionella pneumophila
J A Bridge, P H Edelstein
Antimicrobial Agents and Chemotherapy
|
January 1, 1991
In vitro activity of azithromycin against clinical isolates of Legionella species
P H Edelstein, M A Edelstein
Page
of 12